CAR T cells and metabolic programming: A review
Chimeric antigen receptor (CAR) T cell therapy shown a promising treatment for haematological malignancies. Although it has successful achievement in hematological malignancies, there are major challenges that remain to be resolved to the broad application. To overcome these obstacles, changes in me...
Saved in:
Main Authors: | Shekoufeh Hatami, Fatemeh Kazemi, Parisa Doroudgar, Sahar Shomeil Shushtari, Mohammad Reza Atashzar |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2025-07-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/3155 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of T-cells with chimeric antigen receptor (CAR-T) in combination with chemotherapy and radiotherapy for the treatment of solid tumors
by: M. R. Khaliulin, et al.
Published: (2024-04-01) -
CAR natural killer cell therapy: Natural killer cell activation and expansion
by: P. O. Fedorova
Published: (2024-11-01) -
Does a natural killer need a CAR?
by: Kangbo Wang, et al.
Published: (2025-06-01) -
CAR-T: from bench to bedside
by: M. О. Popova, et al.
Published: (2024-09-01) -
CAR‐NK, a Splendid Strategy for Cancer, Especially for Gynecologic Tumor
by: Yisen Cao, et al.
Published: (2025-06-01)